| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975483 | The Journal of Heart and Lung Transplantation | 2005 | 6 Pages |
Abstract
Simvastatin treatment in heart transplant recipients decreased myocardium TNF-α expression. This decrease did not translate into a difference in the markers of hypertrophy. However, decreased myocardial TNF-α may be a marker of a general statin-mediated decrease in inflammation in the transplanted heart that leads to improved graft and patient survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Cynthia K. MSPH, Sonny J. BS, Seref A. MD, Katy A. BS, John A. MD, Susan C. RN, BSN, Michael M. MD, PhD, George P. MD, Guillermo MD, PhD,